Teva announces management succession
1 January 2012
Dr. Jeremy Levin, a former Senior Executive at Bristol-Myers Squibb, to succeed Shlomo Yanai as President and CEO...
News
The latest news from the pharmaceutical industry. If you have a piece of news that you would like us to cover, please contact Pippa McCartney on +44(0) 1959 563311 or email us.
Pfizer receives FDA approval to extend use of Prevnar 13®
30 December 2011
First pneumococcal conjugate vaccine for adults 50+ has potential to help address high incidence of pneumococcal pneumonia...
FDA to review potential new use of XGEVA® (Denosumab) at ODAC meeting
29 December 2011
FDA has invited Amgen to participate in a meeting of the ODAC on Feb. 8, 2012 to discuss the sBLA for XGEVA® (denosumab)...
Janssen Research & Development submits application to U.S. FDA for XARELTO® (rivaroxaban) to reduce secondary cardiovascular events in patients with ACS
29 December 2011
Janssen Research & Development, LLC (JRD) have announced that it has submitted a sNDA to the FDA seeking approval for the use of XARELTO® (rivaroxaban)...
ICON announces Dr. Anthony Murphy to retire from Board of Directors
27 December 2011
ICON plc., has announced the retirement of Non-Executive Director, Dr. Anthony Murphy to become effective on 31st December 2011...
Bayer’s Xarelto® approved in the EU for the prevention of stroke in patients
20 December 2011
The only new oral anticoagulant approved in three indications across all 27 EU member states...
Amgen and Watson announce collaboration to develop and commercialise oncology biosimilars
20 December 2011
Collaboration reflects the shared belief that the development will not follow a generic model...
Alkermes initiates phase 3 clinical study of ALKS 9070 for treatment of schizophrenia
20 December 2011
ALKS 9070 is designed to offer once-monthly version of Aripiprazole...
AstraZeneca updates on olaparib and TC-5214 development programmes
20 December 2011
With associated impairment charges, company confirms full year financial target...
Roche’s personalised medicine Zelboraf receives positive opinion from European authority
19 December 2011
For the treatment of people with BRAF mutation-positive metastatic melanoma...
Pfizer reports positive results from Phase 3 trial Of Lyrica (pregabaline)
19 December 2011
Patients with Restless Legs Syndrome (RLS) show significant benefit...
PAT supplement
This free to view PAT supplement is sponsored by Sartorius, Extrel, ABB, Bruker Optics and FOSS NIRSystems:
Company directory
ABB Analytical Measurements | Almac | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Daltonik GmbH | CAMO Software AS | CI Precision | Cisbio Bioassays | Colder Products Company | Expo Technologies, LLC. | Freeman Technology | GE Analytical Instruments | HACH LANGE GMBH | HORIBA Scientific | Hudson Robotics, Inc. | Natoli Engineering Company, Inc. | Peter Huber Kältemaschinenbau GmbH | Randox Pharma Services | Rapid Micro Biosystems | Smithers Viscient | Synbiosis | Syngene | Watson-Marlow Pumps Group |
Login to access exclusive content